Date Title Description PDF
26 Jul 2023 On P&L The Company releases the first half 2023 financial results presentation Download
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download

Pages

Date Title Description PDF
08 May 2025 On business and financial situation The Company releases the first three months 2025 financial results presentation Download
08 May 2025 Announcement of General Shareholders’ Meeting The Company announces the call of its 2025 Ordinary General Shareholders' Meeting Download
08 May 2025 On business and financial situation ROVI informs on the award of a grant in its favor to develop the R&D Project IPCEI - ROVI (LAISOLID) Download
04 Apr 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2025 Download
25 Feb 2025 Annual Financial Reports and Audit Reports The Company submits the 2024 Annual Financial Report  Download

Pages

Date Title Description PDF
07 Nov 2011 Otros sobre Gobierno Corporativo Download
19 Oct 2011 I+D resultados obtenidos; licencias, patentes y marcas Download
26 Sep 2011 Acuerdos estratégicos con terceros Download
23 Sep 2011 Acuerdos estratégicos con terceros Download

Pages